Brief
"India’s drug regulator has not adopted AI for regulatory approvals: Govt" is a news brief attributed to MediaNama, dated 6/8/2026. In response to the AI use in drug approval query, J.P. Nadda said CDSCO continues to rely on scientific and technical review for regulatory decisions and the Subject Expert Committee examines clinical trial approvals. The post India’s drug regulator has not adopted AI for regulatory approvals: Govt appeared first on M… It is filed for policy tracker.
This page does not invent an India consequence. If the linked MediaNama article does not state one, treat this as a sourced headline with a short orientation only.
What to do next: open the original MediaNama page, check the wording and date, then follow through to Policy, Jobs, Learn, or Build only if the source itself supports that next step.